Fetal biometry following in-utero exposure to dolutegravir-based or efavirenz-based antiretroviral therapy

被引：2
|
作者：
Banda, Francis M. [1 ]
Powis, Kathleen M. [2 ,3 ,4 ,5 ]
Sun, Shan [6 ]
Makhema, Joseph [2 ]
Masasa, Gosego [2 ]
Yee, Lynn M. [7 ]
Jao, Jennifer [2 ,8 ,9 ]
机构：
[1] Univ Botswana, Dept Paediat & Adolescent Hlth, Fac Med, P Bag 00713, Gaborone, Botswana
[2] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana
[3] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA
[4] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA
[6] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA
[7] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA
[8] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA
[9] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
AIDS | 2020年 / 34卷 / 15期
关键词：
D O I：
10.1097/QAD.0000000000002674
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2336 / 2337
页数：2
相关论文
共 50 条
  • [21] Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention
    Hong, Howard
    Aslam-Mir, Usman
    Kajubi, Richard
    Wallender, Erika
    Mwebaza, Norah
    Dorsey, Grant
    Rosenthal, Philip J.
    Aweeka, Francesca T.
    Huang, Liusheng
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (04)
  • [22] Effect of dolutegravir-based versus efavirenz-based antiretroviral therapy on excessive weight gain in adult treatment-naïve HIV patients at Matsanjeni health center, Eswatini: a retrospective cohort study
    Mukuna, Didier M.
    Decroo, Tom
    Nyapokoto, Clara M.
    AIDS RESEARCH AND THERAPY, 2024, 21 (01)
  • [23] Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir-based antiretroviral therapy
    Dorward, Jienchi
    Govender, Katya
    Moodley, Pravikrishnen
    Lessells, Richard
    Samsunder, Natasha
    Sookrajh, Yukteshwar
    Fanshawe, Thomas R.
    Turner, Philip J.
    Butler, Christopher C.
    Drain, Paul K.
    Hayward, Gail N.
    Garrett, Nigel
    AIDS, 2024, 38 (05) : 697 - 702
  • [24] Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study
    Fernandez-Bargiela, Noelia
    Rotea-Salvo, Sandra
    Margusino-Framinan, Luis
    Balboa-Barreiro, Vanesa
    Martin-Herranz, Isabel
    Castro-Iglesias, Angeles
    Mena-De-Cea, Alvaro
    Lopez-Calvo, Soledad
    Vazquez-Rodriguez, Pilar
    Miguez-Rey, Enrique
    Cid-Silva, Purificacion
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2022, 29 (04) : 207 - 211
  • [25] Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy
    Dorward, Jienchi
    Sookrajh, Yukteshwar
    Lessells, Richard
    Bulo, Elliot
    Bodley, Nicola
    Singh, Lavanya
    Moodley, Pravikrishnen
    Samsunder, Natasha
    Drain, Paul K.
    Hayward, Gail
    Butler, Christopher C.
    Garrett, Nigel
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 95 (05) : e8 - e11
  • [26] Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial)
    Bousmah, Marwan-al-Qays
    Protopopescu, Camelia
    Mpoudi-Etame, Mireille
    Bassega, Pierrette Omgba
    Maradan, Gwenaelle
    Olinga, Justin
    Varloteaux, Marie
    Tovar-Sanchez, Tamara
    Delaporte, Eric
    Kouanfack, Charles
    Boyer, Sylvie
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 94 (03) : 262 - 272
  • [27] Dolutegravir-based Regimen Ensures High Virological Success despite prior Exposure to Efavirenz-based First-Line ART in Cameroon: An Evidence of a Successful Transition Model
    Semengue, Ezechiel Ngoufack Jagni
    Abba, Aissatou
    Angong, Grace
    Christelle, Ka'e Aude
    Bouba, Yagai
    Ceccherini, Francesca
    Chenwi, Collins Ambe
    Colizzi, Vittorio
    Dambaya, Beatrice
    Djupsa, Sandrine
    Etame, Naomi-Karell
    Fokam, Joseph
    Kouanfack, Charles
    Meledie, Alain Patrice
    Mossiang, Leonella
    Ndjolo, Alexis
    Durand, Alex
    Perno, Carlo-Federico
    Martin, Sosso Samuel
    Santoro, Maria Mercedes
    Takou, Desire
    Teto, Georges
    Tchouaket, Michel Carlos Tommo
    SEXUALLY TRANSMITTED DISEASES, 2024, 51 (01) : S169 - S170
  • [28] Pregnancy outcomes following exposure to efavirenz based antiretroviral therapy in indian women
    Mishra, Rajesh Kumar
    Chakravarty, Rony
    Siddique, Nilopher
    Pandey, Kirit Rajendra
    INDIAN JOURNAL OF PHARMACOLOGY, 2020, 52 (06) : 467 - 471
  • [29] Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
    Semengue, Ezechiel Ngoufack Jagni
    Fokam, Joseph
    Etame, Naomi-Karell
    Molimbou, Evariste
    Chenwi, Collins Ambe
    Takou, Desire
    Mossiang, Leonella
    Meledie, Alain P.
    Yagai, Bouba
    Nka, Alex Durand
    Dambaya, Beatrice
    Teto, Georges
    Ka'e, Aude Christelle
    Beloumou, Grace Angong
    Ndjeyep, Sandrine Claire Djupsa
    Abba, Aissatou
    Kengni, Aurelie Minelle Ngueko
    Tchouaket, Michel Carlos Tommo
    Bouba, Nounouce Pamen
    Billong, Serge-Clotaire
    Sosso, Samuel Martin
    Colizzi, Vittorio
    Perno, Carlo-Federico
    Kouanfack, Charles
    Bissek, Anne-Cecile Zoung-Kanyi
    Eben-Moussi, Emmanuel
    Santoro, Maria Mercedes
    Ceccherini-Silberstein, Francesca
    Ndjolo, Alexis
    VIRUSES-BASEL, 2023, 15 (01):
  • [30] Expanding the use of dolutegravir-based antiretroviral therapy in multidrug-resistant TB
    Murphy, R. A.
    Douglas-Jones, B.
    Mucinya, G.
    Sunpath, H.
    Govender, T.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2021, 25 (09) : 696 - +
12345